MedPath

Assessment of tolerance and efficacy of 2nd line S-1 therapy after 1st line GEM for unresectable pancreatic cancer patients

Not Applicable
Conditions
Pancreatic cancer
Registration Number
JPRN-UMIN000000834
Lead Sponsor
agoya University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
14
Inclusion Criteria

Not provided

Exclusion Criteria

1. ascites 2. Myocardiac infarction in the past 3 months 3. Uncontrolled Diabetes Melitus etc

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath